Maginjectable 0,8% Cooper 10x10ml in our organic pharmacy. Give your opinion on the directions for use and dosage with our partner Verified opinions after your purchase.
MAGINJECTABLE 0.8% COOPER is an injectable solution containing magnesium, an essential electrolyte involved in many physiological processes, including neuromuscular transmission, cardiac regulation and cellular metabolism.
It is indicated for the prevention and treatment of magnesium deficiency (hypomagnesemia), particularly when the oral route is insufficient, poorly tolerated or unsuitable. It is used in clinical situations where rapid correction of magnesium levels is required, particularly in the case of neuromuscular (tremors, cramps, hyperexcitability), cardiac or metabolic symptoms associated with deficiency.
Magnesium modulates neuromuscular excitability and helps stabilize cell membranes. It also contributes to the proper functioning of the nervous and muscular systems.
MAGINJECTABLE is reserved for adults and children, under medical supervision. It is particularly indicated for use in hospitals or in supervised care settings, especially in cases of severe deficiency or associated disorders.
According to the official label, Maginject is administered by injection to ensure immediate bioavailability of magnesium.
MAGINJECTABLE 0.8% COOPER should be administered by a qualified healthcare professional.
Dosage is determined by the physician according to :
As a general rule, intravenous administration should be performed slowly to limit the risk of cardiovascular side effects.
Self-administration is not recommended.
The use of MAGINJECTABLE requires particular vigilance due to the injectable route and the effects of magnesium on the body.
In case of unusual symptoms, discontinue administration and consult your doctor immediately.
Give your opinion on the advice for use and dosage of Maginjectable 0,8% Cooper 10x10ml with our partner Verified opinions after your purchase.
Please refer to the official package leaflet for complete and up-to-date information.
MAGINJECTABLE 0.8% COOPER is a magnesium solution for rapid correction of magnesium deficiency. It is indicated in cases of hypomagnesemia requiring parenteral administration, particularly in medical settings. Its action is based on regulation of neuromuscular excitability and stabilization of cell membranes. It is administered intravenously or intramuscularly under medical supervision. Particular care is required in patients with renal insufficiency or cardiac disorders.
This medicine is used to treat or prevent magnesium deficiency, particularly when the oral route is unsuitable or inadequate.
No, this medication must be administered by a healthcare professional, as it is injectable and requires medical supervision.
Undesirable effects may occur, such as hypotension, slow heartbeat or signs of magnesium overdose in the event of excessive administration.
Dosage adjustment is necessary. Use must be cautious and strictly supervised by a physician.
Injectable form provides rapid action and immediate bioavailability, particularly useful in cases of severe deficiency or inadequate digestive absorption.
Certain interactions are possible. It is important to inform your health care professional of all current treatments before administration.
Pharmacovigilance Report an adverse drug reaction(s)
ANSM - Updated on : 16/09/2010
MAGINJECTABLE 0.8 PER CENT, solution for injection
Magnesium
Please read this leaflet carefully before using this medicine. It contains important information for your treatment.
- If you have any further questions, please ask your doctor or pharmacist.
- Keep this leaflet as you may need to read it again.
- If you need more information or advice, ask your pharmacist.
- If symptoms worsen or persist, consult your doctor.
- If you notice any side effects not mentioned in this leaflet, or if you experience any of the effects mentioned as serious, please tell your doctor or pharmacist.
In this leaflet :
1. WHAT IS MAGINJECTABLE 0.8 PER CENT, solution for injection AND WHAT IS IT USED FOR?
2. WHAT DO YOU NEED TO KNOW BEFORE USING MAGINJECTABLE 0.8 PER CENT, solution for injection?
3. HOW DO I USE MAGINJECTABLE 0.8 PER CENT, solution for injection?
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
5. HOW CAN MAGINJECTABLE 0.8 PER CENT, solution for injection, be used?
6. ADDITIONAL INFORMATION
1. WHAT IS MAGINJECTABLE 0.8 PER CENT, solution for injection AND WHAT IS IT USED FOR?
Pharmacotherapeutic class: MINERAL SUPPLEMENT.
Indicated in the treatment of certain major magnesium deficiencies (during parenteral nutrition).
2. WHAT DO I HAVE TO KNOW BEFORE USING MAGINJECTABLE 0.8 PER CENT, solution for injection?
List of information required before use
Not applicable.
Never use MAGINJECTABLE 0.8 PER CENT, solution for injection in case of:
- certain kidney diseases,
- known allergy to magnesium pidolate or glutamates (related substances).
IF IN DOUBT, ASK YOUR DOCTOR OR PHARMACIST FOR ADVICE.
Precautions for use; special warnings
Take special care with MAGINJECTABLE 0.8 PER CENT, solution for injection:
Special warnings
HYPERTONIC SOLUTION TO BE INJECTED SLOWLY.
Initial intravenous administration should be carried out in hospital.
The infusion rate should not exceed 150 mg/minute, i.e. 6 mmol/minute.
Precautions for use
- monitor blood pressure during intravenous injection and continuous infusion,
- monitor magnesemia; discontinue treatment as soon as it has returned to normal,
- reduce dosage in patients with renal insufficiency, with increased monitoring of renal function, blood pressure and blood glucose.
IF IN DOUBT, ASK YOUR DOCTOR OR PHARMACIST FOR ADVICE.
Taking or using other medicines
If you are taking or have recently taken any other medicines, including medicines obtained without a prescription, talk to your doctor or pharmacist.
Interactions with food and drink
Not applicable.
Interactions with herbal products or alternative therapies
Not applicable.
Use during pregnancy and breast-feeding
Pregnancy and breast-feeding
Pregnancy
This medicine should only be used during pregnancy on the advice of your doctor.
Ask your doctor or pharmacist for advice before taking any medication.
Breast-feeding
Breast-feeding should be avoided during treatment.
Ask your doctor or pharmacist for advice before taking any medication.
Not applicable.
Effects on ability to drive vehicles or use machines
Not applicable.
Not applicable.
3. HOW TO USE MAGINJECTABLE 0.8 PER CENT, solution for injection
Not applicable.
Dosage
Strictly in accordance with medical prescription.
Method of administration
Slow intravenous or intramuscular administration.
Strictly in accordance with medical prescription.
Frequency of administration
Strictly in accordance with medical prescription.
Duration of treatment
Strictly in accordance with medical prescription.
Symptoms and instructions in case of overdose
If you have used more MAGINJECTABLE 0.8 PER CENT, solution for injection than you should have:
TELL YOUR DOCTOR IMMEDIATELY.
Instructions in case of missed dose(s)
Not applicable.
Not applicable.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Like all medicines, MAGINJECTABLE 0.8 PER CENT, solution for injection is likely to have undesirable effects, although not everyone is subject to them:
- Pain at injection site, vasodilation with sensation of warmth, metallic taste,
- Hypermagnesemia, potentially lethal in cases of severe renal failure or too rapid injection.
- Allergic-type reactions.
DO NOT HESITATE TO ASK YOUR DOCTOR OR PHARMACIST FOR ADVICE.
If you notice any side effects not mentioned in this leaflet, or if any side effects become serious, please tell your doctor or pharmacist.
5. HOW TO USE MAGINJECTABLE 0.8 PER CENT, solution for injection
Keep out of the reach and sight of children.
Do not use MAGINJECTABLE 0.8 PER CENT, solution for injection after the expiration date stated on the carton.
After opening: use immediately.
No special storage precautions.
If necessary, warnings against certain visible signs of deterioration
Medicines must not be disposed of down the drain or with household waste. Ask your pharmacist what to do with unused medicines. These measures will help protect the environment.
Complete list of active ingredients and excipients
What does MAGINJECTABLE 0.8 PER CENT, solution for injection contain?
The active substance is:
Magnesium pidolate* ........................................................................................................................ 10 g
Per 100 ml injectable solution.
*or magnesium pyrrolidone carboxylate.
Magnesium: 8.14 g/litre
81.4 mg/10 ml ampoule.
Magnesium: 337 mmol/litre
3.37 mmol/10 ml ampoule.
Total osmolarity: 925.6 mOsmol/liter.
The other component is:
Water for injection.
Pharmaceutical form and contents
What is MAGINJECTABLE 0.8 PER CENT, solution for injection and what does it contain?
This medicine is supplied as a solution for injection in ampoules. Boxes of 6, 10, 12, 20 or 100.
COOPERATION PHARMACEUTIQUE FRANCAISE
PLACE LUCIEN-AUVERT
77020 MELUN CEDEX
COOPERATION PHARMACEUTIQUE FRANCAISE
PLACE LUCIEN-AUVERT
77020 MELUN CEDEX
LABORATOIRES COOPERATION PHARMACEUTIQUE FRANCAISE
PLACE LUCIEN AUVERT
77020 MELUN CEDEX
or
LABORATOIRE RENAUDIN
ZONE ARTISANALE ERROBI
64250 ITXASSOU
Drug names in member states of the European Economic Area
Not applicable.
Date of approval of the package leaflet
This leaflet was last approved on {date}.
MA under exceptional circumstances
Not applicable.
Detailed information on this product is available on the Afssaps (France) website.
Information reserved for healthcare professionals
Not applicable.
Not applicable.
This medicine contains magnesium, a mineral essential for metabolism.
It is used to treat magnesium deficiency in infusion-fed patients.
Prices do not include dispensing fees.
| p amp inj | |
| Magnesium pidolate | 1 g |
| i.e. Magnesium | 81.4 mg |
This drug should not be used in cases of severe renal insufficiency.
This drug may interact with drugs containing quinidine or hydroquinidine.
This medicine contains only substances presumed safe for use during pregnancy and lactation.
The solution is injected by infusion, slow intravenous or intramuscular injection.
It is recommended to lie down during injection.
Pain at injection site, sensation of heat.
Metallic taste in the mouth.
Allergic reaction.
Deficiency usually involving nutrients, vitamins, minerals, etc. A diversified diet is the best way to prevent deficiencies.
Inability of the kidneys to eliminate waste products or drug substances. Advanced renal failure does not necessarily mean a reduction in the quantity of urine eliminated. Only a blood test and creatinine level can reveal this disease.
Injection of a drug into a muscle, usually in the buttock. The effect of the drug, which only gradually enters the bloodstream, is delayed but prolonged. The skin must be disinfected beforehand, as this deep injection exposes it to the risk of abscess. Painful injections depend above all on the nature of the product used. This route of administration is contraindicated for haemophiliacs and people on anticoagulant therapy, as it exposes them to the risk of buttock haematoma.
Abbreviation: IM.
Injection of a drug into a vein, usually at the elbow, after disinfecting the skin. In the case of direct intravenous injection using a syringe, the effect of the medication is immediate but brief. Infusion, on the other hand, enables continuous, controlled administration of the active substance, diluted in a vial of serum.
Abbreviation: IV.
All the transformations carried out by the body, leading to the creation of energy or the production of various substances. A distinction is made between anabolism (manufacturing metabolism) and catabolism (degradation metabolism).
Very slow intravenous administration of a substance. The vial is connected to the vein by a flexible, transparent tube, enabling the flow rate to be controlled.
Synonym: drip.
Reaction caused by the body's hypersensitivity to a drug. Allergic reactions can take many forms: urticaria, angioedema, eczema, measles-like rash, etc. Anaphylactic shock is the most common. Anaphylactic shock is a generalized allergic reaction that causes a sudden drop in blood pressure.
See article: Can you be allergic to medicines?
Orotates, bioavailable mineral salts? It was the researcher Hans Nieper who discovered the particular properties of orotates at the end of the 1980s. These mineral salts of orotic acid indeed allow optimal mineralization . Orotatesse are found naturally in animal and plant cells. But how do orotates deposit minerals (magnesium, calcium, chromium, iron, lithium, zinc, etc.) at the heart of the cell, directly in the cell nucleus…
Read the article on the blogMagnesium is involved in the proper functioning of a number of vital mechanisms: bone structure, nervous system, electrolyte balance, psychological balance, etc. Yet almost one person in five has a magnesium deficiency. The Recommended Dietary Allowance (RDA) for magnesium is 420 mg per day for men and 360 mg for women. Hence the importance of making up this magnesium deficit…
Read the article on the blogMagnesium is an essential mineral for our body, playing a crucial role in many biological processes. There are several forms of magnesium, each with its own characteristics and benefits. This article compares two popular forms: marine magnesium and magnesium bisglycinate, to help you decide which one to choose for your needs. What is magnesium? Magnesium is an essential trace element…
Read the article on the blog
